Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
[ad_1] Kena Betancur | Corbis News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Hello and happy Tuesday! Today, we’re unpacking a shocking move from Pfizer. The pharmaceutical giant last week announced … Read more